6-K ·Filed Aug 10, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This is a routine filing with no material new information. Monitor upcoming quarterly results and clinical trial readouts for catalysts. No immediate trading action is warranted based on this filing.
Latest settled — T+20d ⚠ clustered
OCS ▼ -4.70% at T+20d
NEUTRAL call -4.70% · α vs SPY -3.79% · entry $12.76 → $12.16
Latest observation: T+53 +53.37% FF3 residual α
T+1d
-0.08%
call -0.08% · α +0.24%
$12.75
settled 3mo ago
T+5d
+2.98%
call +2.98% · α +3.02%
$13.14
settled 2mo ago
T+20d
-4.70%
call -4.70% · α -3.79%
$12.16
settled 7w ago
T+60d
Pending
in 7d
Price Chart
Loading chart...
Executive Summary
Oculis Holding AG (OCS) filed a Form 6-K with the SEC. The filing contains routine corporate updates and standard regulatory disclosures for a foreign private issuer. No material financial results, clinical trial data, or strategic transactions were identified in the document.
Financial Impact
Not specified
Risk Factors
- No material risks identified in this filing.
- Routine filings typically do not contain new risk disclosures.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-341298 |
| Document: ocs-ex99_1.htm | 0001193125-26-341298 |
| Document: 0001193125-26-341298-index-headers.html | 0001193125-26-341298 |
| Document: 0001193125-26-341298-index.html | 0001193125-26-341298 |
| Document: 0001193125-26-341298.txt | 0001193125-26-341298 |
13 reports for OCS
75% Hit rate @ T+5 Went positive at some point 4 of 4 best @ T+5▲ +50.63%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | 6-K | $8.76 $8.66 | ▼ −1.14% | ▼ −2.44% | $7.83 (−10.62%) |
Aug 10, 2026 11w ago | 6-K | $12.76 $13.14 | ▲ +2.98% | ▲ +3.02% | $7.83 (−38.64%) |
Aug 10, 2026 11w ago | Press Release | $12.76 $13.14 | ▲ +2.98% | ▲ +3.02% | $7.83 (−38.64%) |
Jun 11, 2026 19w ago | Press Release | $11.00 $11.30 | ▲ +2.73% | ▲ +2.29% | $7.83 (−28.82%) |
Jun 9, 2026 20w ago | Press Release | $10.98 $11.61 | ▲ +5.74% | ▲ +3.33% | $7.83 (−28.69%) |
May 29, 2026 21w ago | Press Release | $22.71 $11.21 | ▲ +50.63% | ▲ +48.10% | $7.83 (+65.51%) |
May 11, 2026 24w ago | Press Release | $30.41 $28.07 | ▼ −7.69% | ▼ −7.77% | $7.83 (−74.25%) |
May 11, 2026 24w ago | Press Release | $30.41 $28.07 | ▼ −7.69% | ▼ −7.77% | $7.83 (−74.25%) |
May 7, 2026 24w ago | Press Release | $31.09 $31.37 | ▲ +0.90% | ▼ −0.60% | $7.83 (−74.82%) |
May 5, 2026 25w ago | Press Release | $27.75 $30.41 | ▲ +9.59% | ▲ +7.60% | $7.83 (−71.78%) |
Showing 10 of 13
US Market Status
Market Closed — Opens Wed (17h 28m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers